Lansoprazol Stada

Lansoprazole, the active ingredient in Lansoprazol Stada, is a proton pump inhibitor presented as an oral dosage form for oral use. It treats acid‑related disorders such as gastro‑esophageal reflux disease, peptic ulcer disease, erosive esophagitis and is used in Helicobacter pylori eradication regimens in adult patients.

GNH USA supplies Lansoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazol Stada belongs to the proton pump inhibitor class and is employed to manage acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): reduces gastric acid exposure, relieving heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by maintaining a higher gastric pH. - Erosive esophagitis: facilitates mucosal recovery by limiting acid‑induced injury. - Helicobacter pylori eradication: used in combination therapy to improve bacterial clearance.

Common Side Effects: - Headache: mild to moderate pain, often transient. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach area. - Flatulence: excess gas formation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea, colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: possible hepatic injury. - Stevens‑Johnson syndrome: severe skin reactions. - Interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in elderly: increased risk of fractures. - Review concomitant medications: potential for drug interactions. - Store at room temperature: keep in original container, protect from moisture and light.

Lansoprazol Stada may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - High‑dose methotrexate: increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: altered serum concentrations. - Diazepam: increased plasma levels.